152 related articles for article (PubMed ID: 15516536)
1. Neuropeptide Y and leptin in patients with obstructive sleep apnea syndrome: role of obesity.
Barceló A; Barbé F; Llompart E; de la Peña M; Durán-Cantolla J; Ladaria A; Bosch M; Guerra L; Agustí AG
Am J Respir Crit Care Med; 2005 Jan; 171(2):183-7. PubMed ID: 15516536
[TBL] [Abstract][Full Text] [Related]
2. Impact of Continuous Positive Airway Pressure Treatment on Leptin Levels in Patients with Obstructive Sleep Apnea Syndrome.
Yosunkaya Ş; Okur HK; Can Ü; Zamani A; Kutlu R
Metab Syndr Relat Disord; 2015 Aug; 13(6):272-7. PubMed ID: 25867002
[TBL] [Abstract][Full Text] [Related]
3. Higher levels of plasma TNF-alpha and neuropeptide Y in hypertensive patients with obstructive sleep apnea syndrome.
Li NF; Yao XG; Zhu J; Yang J; Liu KJ; Wang YC; Wang XL; Zu FY
Clin Exp Hypertens; 2010 Jan; 32(1):54-60. PubMed ID: 20144074
[TBL] [Abstract][Full Text] [Related]
4. [Serum neuropeptide Y level in hypertensive patients with obstructive sleep apnea syndrome].
Yao XG; Yan ZT; Li NF; Wang YC; Li T; Zhu J; Zhou L; Shao L
Zhonghua Xin Xue Guan Bing Za Zhi; 2010 Jun; 38(6):510-3. PubMed ID: 21033131
[TBL] [Abstract][Full Text] [Related]
5. The influence of obesity and obstructive sleep apnea on metabolic hormones.
Sánchez-de-la-Torre M; Mediano O; Barceló A; Piérola J; de la Peña M; Esquinas C; Miro A; Durán-Cantolla J; Agustí AG; Capote F; Marin JM; Montserrat JM; García-Río F; Barbé F
Sleep Breath; 2012 Sep; 16(3):649-56. PubMed ID: 21912907
[TBL] [Abstract][Full Text] [Related]
6. Leptin and ghrelin levels in patients with obstructive sleep apnea syndrome.
Ulukavak Ciftci T; Kokturk O; Bukan N; Bilgihan A
Respiration; 2005; 72(4):395-401. PubMed ID: 16088283
[TBL] [Abstract][Full Text] [Related]
7. [Study of serum leptin level in patients with obstructive sleep apnea].
Jin G; Wang W; Kang J; Wu Y; Hou X; Yu R
Zhonghua Jie He He Hu Xi Za Zhi; 2002 Apr; 25(4):204-6. PubMed ID: 12133325
[TBL] [Abstract][Full Text] [Related]
8. Changes in ghrelin, leptin and pro-inflammatory cytokines after therapy in Obstructive Sleep Apnea Syndrome (OSAS) patients.
De Santis S; Cambi J; Tatti P; Bellussi L; Passali D
Otolaryngol Pol; 2015; 69(2):1-8. PubMed ID: 26224223
[TBL] [Abstract][Full Text] [Related]
9. Neuropeptide Y, leptin, galanin and insulin in women with polycystic ovary syndrome.
Baranowska B; Radzikowska M; Wasilewska-Dziubińska E; Kapliński A; Roguski K; Płonowski A
Gynecol Endocrinol; 1999 Oct; 13(5):344-51. PubMed ID: 10599552
[TBL] [Abstract][Full Text] [Related]
10. Effect of continuous positive airway pressure therapy on hypothalamic-pituitary-adrenal axis function and 24-h blood pressure profile in obese men with obstructive sleep apnea syndrome.
Carneiro G; Togeiro SM; Hayashi LF; Ribeiro-Filho FF; Ribeiro AB; Tufik S; Zanella MT
Am J Physiol Endocrinol Metab; 2008 Aug; 295(2):E380-4. PubMed ID: 18523125
[TBL] [Abstract][Full Text] [Related]
11. [Three month continuous positive airway pressure (CPAP) therapy decreases serum total and LDL cholesterol, but not homocysteine and leptin concentration in patients with obstructive sleep apnea syndrome (OSAS)].
Kumor M; Bielicki P; Przybyłowski T; Rubinsztajn R; Zieliński J; Chazan R
Pneumonol Alergol Pol; 2011; 79(3):173-83. PubMed ID: 21509729
[TBL] [Abstract][Full Text] [Related]
12. Obesity and obstructive sleep apnea syndrome.
Acıoğlu E; Yiğit O; Volkan Sunter A; Taşkın U; Berçik İnal B; Sahin M
J Otolaryngol Head Neck Surg; 2010 Dec; 39(6):744-51. PubMed ID: 21144373
[TBL] [Abstract][Full Text] [Related]
13. Continuous positive airway pressure treatment rapidly improves insulin sensitivity in patients with obstructive sleep apnea syndrome.
Harsch IA; Schahin SP; Radespiel-Tröger M; Weintz O; Jahreiss H; Fuchs FS; Wiest GH; Hahn EG; Lohmann T; Konturek PC; Ficker JH
Am J Respir Crit Care Med; 2004 Jan; 169(2):156-62. PubMed ID: 14512265
[TBL] [Abstract][Full Text] [Related]
14. The role of obstructive sleep apnea syndrome and obesity in determining leptin in the exhaled breath condensate.
Carpagnano GE; Resta O; Pergola GD; Sabato R; Foschino Barbaro MP
J Breath Res; 2010 Sep; 4(3):036003. PubMed ID: 21383480
[TBL] [Abstract][Full Text] [Related]
15. Plasma orexin A, orexin B, leptin, neuropeptide Y (NPY) and insulin in obese women.
Baranowska B; Wolińska-Witort E; Martyńska L; Chmielowska M; Baranowska-Bik A
Neuro Endocrinol Lett; 2005 Aug; 26(4):293-6. PubMed ID: 16135994
[TBL] [Abstract][Full Text] [Related]
16. Obstructive sleep apnea syndrome and asthma: the role of continuous positive airway pressure treatment.
Alkhalil M; Schulman ES; Getsy J
Ann Allergy Asthma Immunol; 2008 Oct; 101(4):350-7. PubMed ID: 18939721
[TBL] [Abstract][Full Text] [Related]
17. Leptin measurement in urine is a reliable method of monitoring its secretion in patients with obstructive sleep apnea syndrome.
Chorostowska-Wynimko J; Pływaczewski R; Jończak L; Bednarek M; Stepniewska A; Borowska A; Gorecka D
J Physiol Pharmacol; 2007 Nov; 58 Suppl 5(Pt 1):105-15. PubMed ID: 18204121
[TBL] [Abstract][Full Text] [Related]
18. Obstructive sleep apnoea syndrome, plasma adiponectin levels, and insulin resistance.
Makino S; Handa H; Suzukawa K; Fujiwara M; Nakamura M; Muraoka S; Takasago I; Tanaka Y; Hashimoto K; Sugimoto T
Clin Endocrinol (Oxf); 2006 Jan; 64(1):12-9. PubMed ID: 16402923
[TBL] [Abstract][Full Text] [Related]
19. Cardiovascular risk markers in obstructive sleep apnoea syndrome and correlation with obesity.
Ryan S; Nolan GM; Hannigan E; Cunningham S; Taylor C; McNicholas WT
Thorax; 2007 Jun; 62(6):509-14. PubMed ID: 17251313
[TBL] [Abstract][Full Text] [Related]
20. Comparison of serum adiponectin and tumor necrosis factor-alpha levels between patients with and without obstructive sleep apnea syndrome.
Kanbay A; Kokturk O; Ciftci TU; Tavil Y; Bukan N
Respiration; 2008; 76(3):324-30. PubMed ID: 18487876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
